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Applications of Hidden Markov Models 
in Microarray Gene Expression Data 
Huimin Geng, Xutao Deng and Hesham H Ali 
1Department of Computer Science, University of Nebraska at Omaha, Omaha, NE 68182 
USA 
1. Introduction 
Hidden Markov models (HMMs) are well developed statistical models to capture hidden 
information from observable sequential symbols. They were first used in speech recognition 
in 1970s and have been successfully applied to the analysis of biological sequences since late 
1980s as in finding protein secondary structure, CpG islands and families of related DNA or 
protein sequences [1]. In a HMM, the system being modeled is assumed to be a Markov 
process with unknown parameters, and the challenge is to determine the hidden parameters 
from the observable parameters. In this chapter, we described two applications using 
HMMs to predict gene functions in yeast and DNA copy number alternations in human 
tumor cells, based on gene expression microarray data.  
The first application employed HMMs as a gene function prediction tool to infer budding 
yeast Saccharomyces cerevisiae gene function from time-series microarray gene expression 
data. The sequential observations in HMM were the discretized expression measurements at 
each time point for the genes from the time-series microarray experiments. Yeast is an 
excellent model organism which has reasonably simple genome structure, well 
characterized gene functions, and huge expression data sets. A wide variety of data mining 
methods have been applied for inferring yeast gene functions from gene expression data 
sets, such as Decision Tree, Artificial Neural Networks, Support Vector Machines (SVMs) 
and K-Nearest Neighbors (KNNs) [2-4]. However those methods achieved only about 40% 
prediction precision in function prediction of un-annotated genes [2-4]. Based on our 
observations, there are three main reasons for the low prediction performance. First, the 
computational models are too simple to address the systematic variations of biological 
systems. One assumption is that genes from the same function class will show a similar 
expression pattern. However, clustering results have shown that functions and clusters have 
many-to-many relationship and it is often difficult to assign a function to an expression 
pattern (Eisen et al., supplementary data) [5]. Second, the measurements of expression value 
are generally not very accurate and show experimental errors (or noise). The observed 
expression values may not reflect the real expression levels of genes. For example, a 
correlation as low as 60% was reported between measurements of the same sample 
hybridized to two slides [6]. Third, none of the above methods explicitly address the less 
obvious but significant correlation of gene expressions. Our results indicate that the 
expression value of a gene depends significantly on its previous expression value. 
Therefore, Markov property can be assumed to simplify the non-independence of gene 
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expressions. In this application, we developed a gene function classification tool based on 
HMMs from time-series gene expression profiles (GEP) in yeast and the goal was to provide 
a better tool for more accurate gene function prediction as compared to other existing tools. 
We studied 40 yeast gene function classes which have a sufficient number of open reading 
frames (ORFs) in Munich Information Centre for Protein Sequences (MIPS), for example 
greater than 100, for the training purpose of HMMs. Each function class was modeled as a 
distinct HMM and the set of 40 HMMs compose a discriminant model for unknown gene 
function prediction. Cross-validation showed our HMM-based method outperforms other 
existing methods by an overall prediction precision of 67%.  
In the second application, we developed a DNA copy number alteration (CNA) prediction 
tool based on HMMs to infer genetic abnormalities in human tumor cells from microarray 
gene expression data. The sequential observations in this HMM application were the 
discretized expression measurements for the genes along the chromosomal locations for 
each chromosome. Instead of the temporal order of gene expression in the time-series 
experiments in the first application, in the second application we used the spatial order of 
the genes according to chromosomal locations as the sequential data in HMM. It is well 
known that chromosomal gains and losses play an important role in regulating gene 
expression and constitute a key mechanism in cancer development and progression [7, 8]. 
Comparative Genomic Hybridization (CGH) was developed as a molecular cytogenetic 
method for detecting and mapping such CNAs in tumor cells [9, 10]. However, in the post-
genomic era, the majority of the genome-wide studies in cancer research have been focusing 
on gene expression but not CGH, and as a result, an enormous amount of GEP data have 
been accumulated in public databases for various tumor types [11-15], but few CGH studies 
have been performed in large series of tumor samples [16]. The vast amount of GEP data 
represents an important resource for cancer research, yet it has not been fully exploited. We 
hypothesized that with a well-designed computational model, GEP data can be readily used 
to derive functionally relevant genetic abnormalities in tumors. From the literature review, 
most studies including GEP and CGH have been focusing on the impact of one on the other 
or combining the two for identifying candidate tumor suppressor genes or oncogenes [8, 17-
25]. In this application, we proposed a novel computational approach based on HMMs to 
predict CNAs from the GEP data. It would significantly reduce the cost of CNAs detection 
in tumor cells, and more importantly, it will reveal functionally more relevant CNAs as 
compared to those identified by CGH, since CGH in principle defines only the structural 
changes which may or may not reflect functional effects, but GEP-defined CNAs must have 
the functional effects reflected by changes of gene expression. HMMs have recently been 
applied in array CGH for segmentation, a procedure to divide the signal ratios of each clone 
on the array into states, where all of the clones in a state have the same underlying copy 
number [26, 27]. In this application, HMM was used for an integrative analysis of GEP-to-
CGH prediction which intended to capture two primary sources of uncertainty embedded 
in genomic data: First, the significant but subtle correlations between GEP and CGH; 
Second, the sequential transitions of DNA copy number changes along a chromosome. The 
purpose was to enhance the limited CGH data with the wealth of GEP data and provide an 
integrative genomic-transcriptomic approach for identifying functionally relevant genetic 
abnormalities in cancer research. In this application, we studied 64 cases of Mantle Cell 
Lymphoma (MCL) which had both GEP and CGH data associated. Since chromosomal gains 
and losses occur on individual chromosomes, we developed and trained a separate HMM 
for each chromosome and the set of 24 HMMs compose a discriminant model for the human 
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tumor CNA prediction. Using cross validation, the training of the HMMs was done on the 
paired GEP and CGH data, and the prediction was made for a new tumor sample for its 
CNAs based on the trained HMMs from its GEP data. Our HMM method achieved 75% 
sensitivity, 90% specificity and 90% accuracy in predicting CNAs in 64 MCL samples when 
compared to the CNAs identified by experimental CGH on the same tumor samples.  
2. Preliminary of HMM 
Transition and emission probabilities 
A HMM describes a doubly embedded stochastic process with one observable process 
{Oi} and one hidden process {Hi}. The hidden process {Hi} is an ordinary Markov model 
with state transition distribution defined as aij:  
 0 1 1 1( | , , , ) ( | )ij n n n na P H j H H H i P H j H i− −= = = = = =…  (1) 
where ; aij is the transition probability from hidden state i to j. 
The observable process {Oi} is embedded upon the hidden process with a distinct 
probability distribution eik defined at each hidden state: 
 1 2( | , , , ) ( | )ik n n n ne P O k H H H i P O k H i= = = = = =…  (2) 
where eik is the emission probability of emitting symbol k at hidden state i. 
Together with the initial hidden state distribution π, the HMM with discrete emission 
symbols can be readily represented as a 5-tuple (K, N, aij, eik, π), where K is the number of 
states of the hidden process and N is the number of observations at each hidden state. Given 
the observation sequence O1 O2 …OT, and a HMM, M = (K, N, aij, eik, π), we can efficiently 
compute P(O1 O2 …OT | M), the probability of observing the sequence, by using the Viterbi 
or forward algorithms. In a HMM, the challenge is often to determine the hidden 
parameters from the observable parameters. To estimate the model parameters, when the 
state paths are known for the training datasets, Maximum Likelihood Estimation (MLE) or 
Bayesian Maximum A Posteriori (MAP) can be used; if the state paths are unknown, the 
Baum-Welch algorithm or Viterbi training can be used instead to learn the model 
parameters using a set of observation sequences. To estimate the hidden state path for a new 
case, two standard algorithms Viterbi and Forward-Backward can be used. Refer to Koski 
(2002), Durbin (1989) and Rabiner (1989) for details [1, 28, 29]. 
Viterbi, Forward and Backward Algorithms 
Viterbi decoding is a dynamic programming algorithm. Suppose the probability vk(i-1) of 
the most probable path ending in state k with observation xi-1 is known for all the states k, 
then the probability vl(i) corresponding to the observation xi with the state l can be 
calculated as in Eq. (3). The entire path π can be found recursively as in Algorithm (1). 
 ( ) ( )max( ( 1) )l l i k kl
k
v i e x v i a= −  (3)   
where akl is the transition probability, el(xl) is the emission probability,  k and l are states and 
xi is an emission symbol. 
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Algorithm (1) Viterbi: 
Initialization (i=0): 0(0) 1, (0) 0 for 0.kv v k= = >  
Recursion (i=1…L): ( ) ( )max( ( 1) ); ( ) arg max( ( 1) ).l l i k kl k kl
k k
v i e x v i a ptr l v i a= − = −  
Termination: * *0 0( , ) max( ( ) ); arg max( ( ) ).k k L k k
k k
P x v L a v L aπ π= =  
Traceback (i=1…L): * *1 ( ).i i iptrπ π− =  
 
Posterior decoding is derived from Forward and Backward algorithms, which are similar 
dynamic programming procedures to Viterbi, but by replacing the maximization steps with 
sums to obtain the full probability for all possible paths. In Forward algorithm, 
1( ) ( , )k i if i P x x kπ= =…  is the forward variable, representing the full probability for all the 
probable paths ending in state k with observation up to and including xi. Then ( 1)lf i + , 
which corresponds to the observation up to and including xi+1 and ending in state l, can be 
calculated by the recursion in Eq. (4). In Backward algorithm, the backward variable 
1( ) ( | )k i L ib i P x x kπ+= =…  is analogous to fk(i), but instead obtained by a backward recursion 
starting at the end of the sequence as in Eq. (5). The detailed Forward and Backward 
algorithms are shown in Algorithms (2) and (3). 
 1( 1) ( ) ( )l l i k kl
k
f i e x f i a++ = ∑  (4) 
 
 1( ) ( ) ( 1)k l i kl l
l
b i e x a b i+= +∑  (5) 
 
where akl is the transition probability, el(xl) is the emission probability,  k and l 
{ , , , , , , , , } o o oH H H L L L M M M+ − + − + −∈ and xi { , , }H L M∈ . 
 
Algorithm (2) Forward: 
Initialization (i=0): 0(0) 1, (0) 0 for 0.kf f k= = >  
Recursion (i=1…L): ( ) ( ) ( 1) .l l i k kl
k
f i e x f i a= −∑  
Termination: 0( ) ( ) .k k
k
P x f L a=∑  
 
Algorithm (3) Backward: 
Initialization (i=L): 0( )  for 0.k kb L a k= >  
Recursion (i=L-1…1): : 1( ) ( ) ( 1).k l i kl l
l
b i e x a b i+= +∑  
Termination: 1 0( ) ( ) (1).l l l
l
P x e x a b=∑  
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Having fk(i) and bk(i), given the emitted sequence x, the posterior probability that 
observation xi comes from a state k is shown in Eq. (6). The posterior probability that 
observation xi comes from all possible states in the specific set is shown in Eq. (7), where g(k) 
is a function defined on the states. Then we concatenate the most probable state at each 
position to form an entire state path. 
 ( | ) ( ) ( ) / ( )i k kP k x f i b i P xπ = =  (6)      
 ( | ) ( | ) ( )i
k
G i x P k x g kπ= =∑  (7) 
3. Method 
Application 1—Yeast Gene Function Prediction 
For a set of time-series expression data, we model the discretized expression measurements 
at each time point as observed emission symbols. Our goal is to train separate HMMs for 
each gene function class and use the set of HMMs as a whole discriminant model for 
unknown gene function prediction.  
Data  
The expression data set is obtained from http://rana.lbl.gov/EisenData.htm (Eisen, et al., 
1998) [5]. The complete data set contains 2,467 genes with each gene having 79 experimental 
measurements recorded. Among the 2,467 genes, 2,432 have at least one function annotation 
at MIPS (http://mips.gsf.de/) [30]. For training purpose, we only include 40 function 
classes which have at least 100 open reading frames (ORFs) in MIPS.  
The original data set is organized as a set of pairs {( , )|1 }iS C i n= ≤ ≤iX  where Xi= [Xi1, 
Xi2,…, XiT] is the expression vector and Ci is the class label for the ith training sample, T is 
the number of genes and n is the number of training samples. Expression vectors with the 
same class label are then grouped into the subset {( , )| ,   1 ,  1 }j i iS C C j j L i n= = ≤ ≤ ≤ ≤iX , 
where L is the number of classes.  The entire prediction process can be performed in three 
steps: discretization, training and inference. Discretization is a data preprocessing step in which 
the continuous expression measurements are divided up into a fixed set of intervals 
(symbols). In the training step, the parameters of each distinct unit of HMM, Mi, are 
specified by using each training subset Si. The whole model { |1 }iM M i L= ≤ ≤  is a 
collection of unit models and used for inference of gene functions. 
Model Structures 
One advantage of HMMs is that designers can choose arbitrary transition and emission 
structures appropriate for modeling data from specific domains. In this application, two 
model structures were considered for modeling the sequential time-series microarray gene 
expression data (Figure 1). Model A defines states based on time sequence of experiments. 
This model is the backbone of the HMM for protein profiling [1, 31]. The advantage of 
model A is that the position-specific information is preserved. However, if we take a closer 
look, all transitions are of probability 1 and the HMM is actually degenerated into a weight 
matrix which doesn’t consider the non-independence of data. To reflect the dependence of 
the expression data at different time points, we designed model B by combining the 
expression values and the experiment sequence as states. The state is defined as a pair, 
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(value, experiment). If an expression value is below a predefined threshold at time point i, the 
state is “low-i”; otherwise it is “high-i”. Model B is a more complex model which is able to 
capture the Markov property of expression data. However, model B has more parameters 
than model A and hence requires a larger number of training samples. The model A is 
referred to “chain HMM” and model B as the “split HMM”. 
                            
B: Begin State; E: End State; Hi: High State; Lo: Low State 
A 
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Fig. 1. Two HMM model structures for modeling yeast time-series microarray gene 
expression data. Left panels are state transition diagrams and right panels are expression 
patterns. A. States defined based on experiment order (i.e. time points). B. States definition 
according to both expression value and experiment order. Note that “B” and “E” are special 
dummy states without emission. 
Training  
In this section, we describe the training of prior distribution P(Mi), transition distribution 
(aij) and emission distribution (eik) for each gene function class. All the distributions are 
considered as a multinomial distribution with certain unknown parameters. We will use 
Bayes’ learning to determine the point estimator of all unknown parameters from the data. 
The prior probability density function P(Mi) is estimated by the Maximum Likelihood 
Estimator (MLE) of a multinomial distribution as in Eq. (8): 
 
1
| |ˆ( )
| |
i
i L
i
i
S
P M
S ′′=
= ∑  (8) 
where  | |iS  is the number of training samples in the ith class and L is the number of classes. 
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The transition probability distribution can be modeled as a multinomial distribution 
1 2( , ,..., )i i iKiMul a a a . We use a Dirichlet distribution Dir(1, 1, …, 1) as the conjugate prior to 
avoid the problem of zero probability. Therefore, the Mean Posterior Estimator for the 
transition probability aij is defined as in Eq. (9): 
 
'
' 1
1
ˆ  , 1 ,  1
i
ij
ij iK
ij i
j
A
a i K j K
A K=
+= ≤ ≤ ≤ ≤+∑  (9) 
where Aij is the count of transitions from state i to j in the training samples, K is the number 
of states defined in the HMM, and Ki is the out-degree of state i (i.e., Ki=1 in the chain HMM, 
, and Ki =2 in the split HMM). Similar to the transition probabilities, emission probabilities 
can be estimated by counting the frequencies as well in Eq. (10), 
 
'
' 1
1
ˆ , 1 ,  1
ij
ij N
ij
j
E
e i K j N
E N=
+= ≤ ≤ ≤ ≤+∑  (10) 
where Eij is the count of emissions of symbol j at state i in the training samples, K is the 
number of states defined in the HMM, and N is the total number of symbols at each state.  
The training was performed for each function class. 
Inference 
Given an expression vector X and the model M (a collection of each unit model Mi), inferring 
the function of X is performed based on Bayes’ theorem: 
 ( | ) ( | ) ( )i i iP M P M P M∝X X  (11) 
In order to calculate the posterior probability P(Mi|X), we need the prior probability of each 
P(Mi) and the likelihood P(X|Mi). P(Mi) is specified in Eq. (8). The likelihood P(X|Mi) can be 
considered as the marginal probability of X across all hidden state paths π.  
  0 1 ( ) ( 1) ( ) ( )
1
( | ) ( , | )
T
i i l l l X l
l
P M P M a a eπ π π ππ ππ +== =∑ ∑ ∏X X  (12) 
where π(l) is the lth hidden state in the path π and X(l) is the symbol at the lth state. Once the 
parameters of the HMM Mi have been determined from training data, the likelihood term 
can be efficiently computed by the forward algorithm, as described previous section 
Preliminary of HMM. The inference of function class is then made by choosing the most 
likely class given the data, as in Eq. (13).  
  * arg max ( | ) arg max ( | ) ( )
i i
i i i
M M
M P M P M P M= =X X  (13) 
Application 2—Human Tumor CNA Prediction 
In the second application, HMMs are used to address the following question: “Given a 
sequence of gene expression data along chromosomal locations as observations, predict the 
hidden CGH status of the chromosomal gains or losses.” 
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Model Structure  
In the HMM-CNA prediction, the observable process {Oi} describes discretized gene 
expression values of genes along a chromosome, where Oi =“H”, “L” or “M” for high, low or 
medium expression, respectively; the hidden process {Hi} describes the underlying CNAs, 
where Hi =“+”, “-” or “o” for gain, loss or normal copy number status of a gene, respectively. 
In Figure 2A, the HMM model was illustrated as a Bayesian network, where the shaded 
nodes S1, S2, …, Sn represent hidden state variables, and the visible nodes E1, E2, …, En 
represent the observations for the variables, for the genes along a chromosome. The 
emission space consists of three symbols {H, L, M} and the hidden state space consists of 
nine states that the gene expression values superimposed on the CNAs {H+, L+, M+, H-, L-, M- 
, Ho, Lo, Mo} , where Eα emits E, { , , }E H L M∈  and { , , }oα ∈ + − . Figure 2B showed the state 
transition diagram. The model is a single chain incorporating three Markov sub-chains. In 
each sub-chain, there is a complete set of state transitions, describing the elongation of a 
DNA segments with a gain, loss or normal copy number. The state transitions between sub-
chains are also allowed to describe the state change of a gain, loss or normal CNA. This 
design of intra- and inter- sub-chain transitions in HMM makes it possible to identify 
alterative gain, loss and normal regions of variable length automatically.  
 
A 
S1 …Chromosome S2 Sn
E1 E2 En  
 
B 
H+
M+
L+ H-
M-
L-
Ho
Mo
Lo
sub-chain (+)
sub-chain (o)
sub-chain (-)  
Fig. 2. HMM model structure for human CNA prediction. (A) HMM model presented as a 
Bayesian network. The shaded nodes S1, S2, …, Sn represent hidden state variables and the 
white nodes E1, E2, …, En represent the observations for the variables. (B) State transition 
diagram of HMM-CNA model. The model is a single HMM chain integrating three Markov 
sub-chains: (+), (-) and (o). In each sub-chain, a Markov chain is graphically shown as a 
collection of states, with arrows between them describing the state transitions within a gain, 
loss or normal CNA. There are also arrows between sub-chains, describing the state 
transitions from a gain, loss or normal CNA to another. 
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Training 
Since chromosomal gains and losses are based on individual chromosomes, we developed 
and trained a separate HMM for each chromosome accordingly. The whole HMM-CNA 
prediction model was made of individual HMMs. In our training dataset, given the paired 
GEP and CGH data, the hidden state path for each observation sequence is known. 
Therefore, the transition and emission probabilities can be estimated using MLE as in Eq. (9) 
and (10). 
Inference 
Having the model parameters trained by training data, we used Viterbi or Posterior (also 
called Forward and Backward) decoding algorithms [1] to infer hidden CNA states for a 
new tumor sample based on its GEP observations. Viterbi algorithm works by finding the 
highest probability path as a whole as a hidden state path, while alternatively, Posterior 
algorithm finds the most likely state for each position and then concatenate those states as a 
hidden state path. The detailed algorithms of Viterbi and Posterior decoding were shown in 
Preliminary of HMM section. 
An alternative inference method for HMM when given only emissions (i.e. GEP 
observations) as training data is the Baum-Welch algorithm [1], which estimates the model 
parameters (transition and emission probabilities) together with unknown CGH states by an 
iterative procedure. We chose not to use this algorithm as there are many parameters in the 
model, but relatively few data points at each gene position to estimate these parameters. 
Instead, we use the true CGH states to guild the HMM prediction using the Viterbi or 
Posterior algorithms. 
Smoothing Algorithm 
Since gains and losses identified by our experimental CGH had the resolution on cytobands, 
we determined the gains and losses on cytoband resolution as well by applying the 
following smoothing method. Basically, a multinomial probability was used to measure the 
likelihood of a cytoband harboring a gain/loss or not. In Eq. (14), L is the likelihood under a 
hypothesis H, where H1 for the alternative hypothesis that “a cytoband is harbouring a gain 
or loss”, and H0 for the null hypothesis that “a cytoband is not harbouring a gain or loss”; 
n+, n-, and no are the numbers of genes in the gain, loss and normal status within this 
cytoband, and n is the total number of genes on this cytoband, n=n++n-+no; θ+, θ- and θo are 
the corresponding multinomial parameters which can be estimated using MLE  in Eq.(15). 
Under H1, θ1,+, θ1,- and θ1,o are estimated by the number of genes n+, n- and no on a cytoband 
(n=n++n-+no), while under H0, θ0,+, θ0,- and θ0,o are estimated by the number of genes N+, N- 
and No on the whole genome as background (N=N++N-+No). Log-of-odds (LOD), which is 
Log10 of the ratio of the two likelihoods, was used to measure how likely that the cytoband 
harbors a gain or loss in Eq. (16). The higher the LOD score, the more likely this cytoband 
harbors a genomic gain or loss. 
 
!
( , , | )
! ! !
onn n
o o
o
n
L n n n H
n n n
θ θ θ+ −+ − + −+ −= , (14) 
 1, 1, 1, 0, 0, 0,,  ,   and ,  ,  
o o
o o
n Nn n N N
n n n N N N
θ θ θ θ θ θ+ − + −+ − + −= = = = = =  (15)        
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 1, 1, 1,110 10
0 0, 0, 0,
( , , | )
log log
( , , | )
o
o
nn n
oo
nn n
o o
L n n n H
LOD
L n n n H
θ θ θθ θ θ+ −+ −+ −+ −+ − + −= =  (16) 
Other Simple Methods 
To compare with HMM, we also made two other simple methods, rGEP (raw GEP) and 
sGEP (smoothing GEP), to map the GEP status to CGH status without a sophisticated 
learning and inference process. By rGEP, we mean that a high expression status of a gene is 
mapped to a gain (i.e. “H” → “+”), low expression to a loss (i.e. “L” → “-”), and medium 
expression to a normal (i.e. “M” → “o”) status. In sGEP, a smoothing method (a multinomial 
model, as described above) was applied after rGEP to get a gain or loss status for a cytoband 
across a number of consecutive genes. 
Data 
The data we used in this application include 64 MCL samples performed with both GEP and 
CGH experiments [22]. The GEP data were obtained using Affymetrix HG-U133 plus2 
arrays and normalized (global median normalization) using BRB-Array Tool [32]. 1.5-fold 
change was adopted to determine high (>1.5 fold increase), low (>1.5 fold decrease) or 
medium (<1.5 fold change) expression of each gene in a tumor case as compared to the 
median expression of this gene across all tumor cases. The CGH experiments were 
performed by Vysis CGH kits (Downers Grove, IL). aCGH-Smooth [33] was used to 
determine breakpoints and relative levels of DNA copy number. The company 
recommended 1.25 and o.75 signal ratio of tumor to normal cells was used to segregate gain 
(>1.25), loss (<0.75) and normal (between 0.75 and 1.25) regions. Small-sized chromosomes 
and sex chromosomes were excluded from the study due to technical limitation and lack of 
gender data, including chromosomes 19-22, X and Y. The chromosomal locations of genes 
and cytobands were obtained by Affymetrix probesets alignments and NCBI Human 
Genome database Build 36.1. The LOD score of 2 was used as the cutoff to call a gain or loss 
for a cytoband after the smoothing algorithm. 
4. Results 
Evaluation criteria 
The prediction performs were evaluated using cross validation, in which the set of samples 
was divided up into the training set and the test set. The total n samples were randomly 
split into k subsets of equal size. We use each subset as the test set and the other k-1 subsets 
as the training set (which is called k-fold cross validation). In the extreme case where one 
case was used in the test set and all the other n-1 cases were used in training, it is called 
leave-one-out cross validation (LOOCV). K-fold cross validation or LOOCV were used to 
validate the HMMs in the two studies. 
The performance of predictions was evaluated using the criteria of precision, recall, sensitivity, 
specificity and accuracy, defined as below:  
 
| |
| | | |
TP
precision
TP FP
≡ +  (17) 
 
| |
| | | |
TP
recall sensitivity
TP FN
≡ ≡ +  (18) 
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| |
| | | |
TN
specificity
TN FP
≡ +  (19) 
 
| | | |
| | | | | | | |
TP TN
accuracy
TP TN FP FN
+≡ + + +  (20) 
where |TP| means the number of true positive, |FP| for false positive, |TN| for true 
negative, and |FN| for false negative. 
Application 1—Yeast Gene Function Prediction 
Many factors affect prediction performance, such as the model structure, the size of training 
data and the number of predictions made. We performed experiments for different settings 
and search for the setting at which the best performance was achieved. A graphical output of a 
trained split HMM model is shown in Figure 3 for function class 32 (cell rescue, defense and 
virulence in Table 1). Only the first eight expression measurements are shown. Six emission 
symbols plus a missing symbol are color-coded corresponding to the relative expression level 
in the microarray image. The thickness of each edge represents the transition probability. The 
width of each vertical bar represents the probability of each symbol at a specific state. It is 
obvious that in the high expression value state (at top of the chain), the observed expression 
measurements are also relatively high (the bar widths are wider at 3 to 6); while in the low 
expression value state (at bottom of the chain), the observed expression measurements are also 
relatively low (the bar widths are wider at 0 to 2). 
Since a single gene may have multiple functions, we can make multiple predictions for a 
testing gene. Besides choosing the function class with the highest posterior probability, we 
 
 
Fig. 3. HMM training results for class 32 (cell rescue, defense and virulence). Only the first 
eight expression measurements are showed here. Six emission symbols plus a missing 
symbol are color-coded corresponding to the relative expression level in the microarray 
image (red high expression and green low expression). The thickness of each edge 
represents the transition probability. The width of each vertical bar represents the 
probability of each symbol at a specific state.  
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can choose the second highest, the third highest, and so on. This procedure is termed single-
dip, double-dip, and trip-dip, etc. The prediction performance at different dips was shown in 
Figure 4c. The precisions achieved for single- and double- dip settings are about 60% or higher 
and for triple-dip is about 50%. The recalls are around 30% for single-dip, but can reach 51% 
when multiple predictions are made (triple-dip). The overall prediction accuracy is 
significantly higher than that of SVMs and KNNs (40% precisions, 30% recalls). From Figure 
4c, we can also see that precision and recall are inherently conflicting measures such that 
improving one will often be at a cost of the decrease of the other if other conditions are same. 
From Figure 4a and Figure 4b, the number of TPs, the number of predictions (TPs+FPs), 
precision and recall generally increase as the size of training set increases. At the n-fold cross 
validation (i.e. LOOCV), HMM-based method achieved an overall prediction precision of 
67%, which outperforms other existing methods (40% precisions in SVMs and KNNs). From 
Figure 4a and 4b, we also observed that the split HMMs seem to be a more conservative 
method than the chain HMMs. At the same level of fold, the chain HMMs tend to have 
higher TPs and recalls than the split HMMs, but lower precisions than the split HMM.  
Precision is the most important evaluation measurement for prediction, because it tells 
directly how likely the prediction is correct. Recall, on the other hand, tells how sensitive the 
prediction is. Figure 4d shows that the split HMMs generate higher precisions than the chain 
HMMs at the same level of recall. However, in general the chain HMMs show higher recalls 
than the split HMMs. Table 1 shows the detailed prediction results for each function class of 
genes. Only five classes have a precision less than 60%. 
 
 
Fig. 4. Testing results of various experiment settings. a. comparison of recalls between chain 
HMM and split HMM. b. comparison of precisions between chain HMM and split HMM. c. 
pattern of precisions and recalls for multiple predictions. d. relationship between precisions 
and recalls. 
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Function 
Entry 
Annotation |TP| |TP|+|FP| |TP|+|FN| Precision Recall 
01 metabolism 199 295 631 67.5% 31.5% 
01.01 amino acid metabolism 24 29 137 82.8% 17.5% 
01.03 nucleotide metabolism 15 24 94 62.5% 16.0% 
02 energy 72 105 159 68.6% 45.3% 
10 
cell cycle and DNA 
processing 
203 342 388 59.4% 52.3% 
10.01 DNA processing 42 47 186 89.4% 22.6% 
10.01.03 
DNA synthesis and 
replication 
3 3 77 100% 3.9% 
10.03 cell cycle 44 64 265 68.8% 16.6% 
10.03.01 
mitotic cell cycle, cell 
cycle control 
16 17 217 94.1% 7.4% 
10.03.02 meiosis 1 1 44 100% 2.3% 
11 transcription 346 623 553 55.5% 62.6% 
11.02 RNA synthesis 92 157 354 58.6% 26.0% 
11.04 RNA processing 56 76 170 73.7% 32.9% 
11.04.01 RNA processing 21 34 54 61.8% 38.9% 
11.04.03 
mRNA processing 
(splicing, 5'-, 3'-end 
proc) 
16 16 100 100% 16.0% 
12 protein synthesis 162 204 300 79.4% 54.0% 
12.01 ribosome biogenesis 105 108 176 97.2% 59.7% 
14 
protein fate (folding, 
modification, 
destination) 
176 285 448 61.8% 39.3% 
14.07 protein modification 16 16 139 100% 11.5% 
14.13 protein degradation 40 43 116 93.0% 34.5% 
14.13.01 
cytoplasmic and 
nuclear protein 
degradation 
29 29 83 100% 34.9% 
20 
cellular transport, 
transport facilitation 
and routes 
207 392 431 52.8% 48.0% 
20.01 
transported compounds 
(substrates) 
36 42 151 85.7% 23.8% 
20.03 transport facilitation 7 7 79 100% 8.9% 
20.09 transport routes 64 112 367 57.1% 17.4% 
20.09.18 cellular import 5 5 95 100% 5.3% 
32 
cell rescue, defense and 
virulence 
43 56 143 76.8% 30.1% 
32.01 stress response 21 27 92 77.8% 22.8% 
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Function 
Entry 
Annotation |TP| |TP|+|FP| |TP|+|FN| Precision Recall 
32.07 detoxification 5 6 49 83.3% 10.2% 
34 
interaction with the 
cellular environment 
42 45 212 93.3% 19.8% 
34.01 ionic homeostasis 9 9 89 100% 10.1% 
34.01.01 homeostasis of cations 3 3 83 100% 3.6% 
34.11 
cellular sensing and 
response 
21 22 125 95.5% 16.8% 
34.11.03 
chemoperception and 
response 
21 22 125 95.5% 16.8% 
42 
biogenesis of cellular 
components 
72 108 263 66.7% 27.4% 
42.01 cell wall 7 7 84 100% 8.3% 
42.04 cytoskeleton 6 7 71 85.7% 8.5% 
42.16 mitochondrion 36 46 71 78.3% 50.7% 
43 cell type differentiation 12 12 193 100% 6.2% 
43.01 
fungal/microorganismi
c cell type 
differentiation 
12 12 193 100% 6.2% 
Total  2307 3458 7607 66.7% 30.3% 
Table 1. Detailed prediction results on 40 gene classes in yeast time-series gene expression 
dataset [5]. For training purposes in HMM, only 40 gene classes were included which have 
at least 100 ORFs in MIPS. The results were based on the split-HMMs using 3-fold cross 
validation. 
Application 2—Human Tumor CNA Prediction 
Using cross validation, HMM-CNA was applied to 64 MCLs, on which both GEP and CGH 
experiments were performed [22]. The entire dataset was split into training and testing 
datasets. In the training dataset, the HMM model was trained by the paired GEP and CGH 
data on the same tumor samples, and in the testing dataset, the specified HMM model was 
applied to the GEP data for a new tumor sample to predict its CNAs. The predicted gains 
and losses were compared with those identified by experimental CGH on the gene level for 
the sensitivities and specificities, and on the cytoband level for the recurrent genetic 
abnormalities.  
Gene-Level Validation 
We first evaluated HMM Viterbi decoding method by sensitivity, specificity and accuracy 
against experimental CGH in predicting gain and loss of each gene for all the samples using 
LOOCV. For comparison purpose, the performance of rGEP and sGEP methods were also 
included. Table 2 summarized the average sensitivity, specificity and accuracy for all 
chromosomes on 64 MCL samples. Figures 5 showed the performance on individual 
chromosomes for sensitivity (A) and specificity (B). In general, sensitivity was improved from 
40% in GEP to 45% in sGEP and to 75% in HMM, and specificity from 70% in GEP to 85% in 
sGEP and to 90% in HMM, in predicting gain; in predicting loss, sensitivity from 30% in GEP 
to 50% in sGEP and to 60% in HMM, and specificity from 80% in GEP to 90% in sGEP and 
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HMM. These results suggested that the HMM were able to capture the hidden genomic 
CNA information buried in the GEP data; while directly mapping GEP status to CGH status 
without any learning process, such as rGEP and sGEP methods, could not predict well. 
 
 Sensitivity (%) Specificity (%) Accuracy (%) 
rGEP 38.45± 2.93 71.43± 0.58 69.46± 1.50 
sGEP 42.77± 10.42 86.33± 2.97 83.59± 3.48 
 
Gain 
HMM 74.49± 17.77 88.56± 4.78 87.50± 5.59 
rGEP 28.26± 3.70 80.94± 0.70 77.71± 3.47 
sGEP 50.66± 24.13 92.71± 2.00* 89.19± 3.63 
 
Loss 
HMM 59.63± 17.22 90.63± 4.91 89.30± 5.69 
Table 2. Sensitivity, specificity and accuracy of HMM, rGEP and sGEP as compared to 
experimental CGH. 
The HMM prediction were good for the majority of chromosomes, but we noticed that on 
some chromosomes HMM prediction was not good, such as chromosomes 1, 6, 9, 10 and 13 
for gain and chromosomes 4, 5, 15 and 18 for loss. This is due to infrequent aberrations and 
hence insufficient training data for the gains or losses on those chromosomes. For example, 
in the CGH data of the 64 MCL cases, only one, three, one, two and one cases were observed 
with gain on chromosomes 1, 6, 9, 10 and 13, respectively, and two, one, one and two cases 
with loss on chromosomes 4, 5, 15 and 18, respectively.  
Cytoband-Level Validation 
Cytobands are defined as the chromosomal areas distinguishable from other segments by 
appearing darker or lighter by one or more banding techniques for karyotype description. 
To compare HMM prediction with the “gold standard” experimental CGH on the same 
resolution (our experimental CGH detected gains and losses on cytobands), we also 
determined cytoband-level gains and losses from HMM by applying a smoothing algorithm 
as described in Method section.  
Figures 6 showed the results of cytoband level gains and losses on MCL dataset. The two 
HMM decoding methods, Viterbi and Posterior, were shown in panels A and B, 
respectively, where loss frequencies for cytobands (i.e. the number of cases harboring a loss 
on a cytoband) were shown on left-sided bars and gain frequencies on right-sided bars. In 
Posterior decoding (Figure 6B), as expected, the frequencies of gains and losses decrease as 
posterior probability increases (p=0.5, 0.6, 0.7, 0.8 and 0.9), and those frequencies are highly 
correlated (Pearson's correlation coefficients around 0.99, Table 3). Comparing the results 
from Viterbi (panel A) and Posterior (panel B), a high concordance was also observed 
(Pearson's correlation coefficients around 0.98, Table 3). Therefore, the Viterbi method was 
used to represent HMM in comparison of the experimental CGH side by side in panel C.  
Table 3 showed that Pearson's correlation coefficients between HMM and CGH are around 
0.8 for gains and losses. In Figure 6C, gains and losses were shown separately with CGH 
results colored yellow above X axis and HMM results colored red below X axis. Apparently, 
the majority of the frequent gains and losses predicted by HMM are in good concordance 
with those identified by experimental CGH, such as gains of 3q, 7, 8q, 15q and 18 and losses 
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Fig. 5. Sensitivity (A) and specificity (B) in predicting gain and loss regions by GEP, sGEP 
and HMM in 64 MCL. 
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of 1p21-p31, 6q, 8p, 9p, 9q, 11q21-q23, 13 and 17p13-pter. Those regions have also been 
revealed as high-frequency chromosomal alteration regions in various studies using 
conventional cytogenetics, CGH and array CGH {Bea, 2005 #38}.  
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30
20
10
0
10
20
30 CGH vCGH
30
20
10
0
10
20
30 CGH vCGH
1         2            3         4         5         6        7 8      9     10    11    12    13    14   15  16  17  18
Chromosomes 
1         2            3         4         5         6        7 8      9     10    11    12    13    14   15  16  17  18
Chromosomes 
CGH vCGH
CGH vC H
Gain
Loss
20   10    0    10   20
Number of cases
20    10     0    10    20
Number of cases
chr1
chr2
chr3
chr4
chr5
chr6
chr7
chr8
chr9
chr10
chr11
chr12
chr13
chr14
chr15
chr16
chr17
chr18
Loss 0.9
Loss 0.8
Loss 0.7
Loss 0.6
Loss 0.5
Gain 0.9
Gain 0.8
Gain 0.7
Gain 0.6
Gain 0.5
Loss  Gain                         Loss  Gain
N
u
m
b
e
r 
o
f 
c
a
s
e
s
N
u
m
b
e
r 
o
f 
c
a
s
e
s
N
u
m
b
e
r 
o
f 
c
a
s
e
s
N
u
m
b
e
r 
o
f 
c
a
s
e
s
 
Fig. 6. Cytoband-level gains and losses by HMM and CGH on 64 MCLs. (A) HMM Viterbi 
method. (B) HMM Posterior method with a series of probability cutoffs (p=0.5, 0.6, 0.7, 0.8 
and 0.9). In (A) and (B), left-sided bars correspond to losses whereas right-sided bars to 
gains. On Y axis are the cytobands ordered from pter to qter (from top to bottom) for each 
chromosome and on X axis, the length of each bar indicates the gain and loss frequencies, 
i.e. the number of cases harboring a gain or loss on a cytoband. (C) Comparison of HMM 
and CGH where Viterbi method was used to represent HMM. Gain and loss were shown 
separately. CGH results were shown in yellow (above X axis) and HMM prediction were 
shown in red (below X axis).  On X axis, each bar represents a cytoband ordered from pter to 
qter for chr1 to chr18. On Y axis, the height of each bar indicates frequency, i.e. the number 
of cases horboring a gain or loss on a cytoband. 
There are also some limitations of the approach due to utilization of transcripts-based GEP 
data. For example, it may not predict well for regions with few genes (also called “gene 
desert”), or if the genes in a region are not expressed at a sufficiently high level for GEP. The 
HMM approach is also limited by the design of the GEP arrays. For example, on Affymetrix 
HG-U133 plus 2 platform, there are no probes distributed on the p arms of chromosomes 13, 
14, 15, 21 and 22, and hence those regions are unpredictable for gains or losses by HMM. 
5. Conclusions  
In this chapter, we demonstrated two applications using HMMs to predict gene functions 
and DNA copy number alternations from microarray gene expression data. In the first 
application of HMM on yeast time-series expression data, the overall prediction accuracy of 
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HMM Posterior  
CGH 
HMM 
Viterbi p_0.5 p_0.6 p_0.7 p_0.8 p_0.9 
CGH 1 0.766 0.734 0.745 0.744 0.752 0.756 
HMM Viterbi 0.828 1 0.970 0.978 0.978 0.978 0.973 
p_0.5 0.831 0.978 1 0.990 0.986 0.982 0.969 
p_0.6 0.828 0.980 0.996 1 0.996 0.991 0.978 
p_0.7 0.828 0.983 0.992 0.995 1 0.993 0.981 
p_0.8 0.827 0.985 0.988 0.992 0.996 1 0.990 
H
M
M
 P
o
st
e
ri
o
r 
p_0.9 0.820 0.981 0.983 0.986 0.991 0.993 1 
Table 3. Pearson correlation of cytoband-level gain and loss frequencies between CGH, 
HMM Viterbi, and HMM Posterior. Gain were shown in the bottom, and loss in the top 
triangles. 
our model is significantly higher than that of SVMs and KNNs. A properly designed HMM 
is capable of modeling the three features of expression data: pattern variation within a class, 
experimental noise, and Markov property. The extraordinary flexibility of HMMs allows us  
to extend the current model in several directions. One of the current developments is to 
extend the HMM model to Bayes nets for functional prediction from heterogeneous data 
sets. With appropriately constructed conditional distribution, all kinds of available data can 
be applied for training and inference using Bayesian network model. Besides the functional 
prediction of unknown ORFs, one potential application of this method is to search for ORFs 
of functional homology in databases. To do this, a proper cut-off likelihood value (or 
equivalently a LOD score) must be specified. Whenever a homolog is found (i.e., beyond the 
cut-off value), it may be included as a training set to reinforce the training process.  
In the second application of HMM on the human tumor microarray gene expression data, 
we proposed a novel computational approach based on HMMs to predict genetic 
abnormalities in tumor cells. Taking advantage of the rich GEP data already publicly 
available, HMM may significantly enhance the identification of genetic abnormalities in 
cancer research. Our model is among the first which employed HMM for the purpose of 
GEP-to-CGH prediction. We expected the HMM to capture two primary sources of 
uncertainty embedded in genomic data: the significant but subtle correlations between GEP 
and CGH, and the sequential transitions of CNAs along chromosomes. We applied the 
HMM model to 64 MCL samples and using cross validation, HMM achieved 80% 
sensitivity, 90% specificity and 90% accuracy in predicting gains and losses as compared to 
the experimental CGH on the same tumor cases. The recurrent gains and losses predicted by 
HMM on cytobands were concordant with those identified by CGH. In addition, our model 
does not only highlight DNA CNA regions but also served as an integrative tool cross-
linking genomic and transcriptiomic data for functionally relavent genomic abnormal 
regions. As this HMM-based method is a general computational tool which can be applied 
to any types of tumors, it may significantly enhance the identification of genetic 
abnormalities in cancer research. To improve the model, we plan to add relevant biological 
parameters to preprocess or filter the data in prediction. We will consider gene densities, 
transcriptional units, regional epigenomic silencing, genes that not expressed in normal 
samples, common “genomic aberrations”, and human genomic copy number polymorphism 
in the model. 
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